References

Ahrén B. (2003) Gut peptides and type 2 diabetes mellitus treatment. Curr Diab Rep; 3:365–372.

Deacon CF, Nauck MA, Toft-Nielsen M, et al. (1995) Both subcutaneously and intravenously administered glucagon-like peptide 1 are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes; 44:1126–1131.

Related posts:

Overview of Current Diabetes Management Organization of Diabetes Care Sodium-glucose Cotransporter-2 Inhibitors Epidemiology and Pathogenesis of Type 2 Diabetes Dipeptidyl Peptidase-4 Inhibitors The Incretin Mimetics

Stay updated, free articles. Join our Telegram channel

Join